Table 1 Baseline characteristics stratified by follow-up outcome
Overall population (n = 204) | With event (n = 30) | Without events (n = 174) | p value | |
|---|---|---|---|---|
Baseline clinical | ||||
Age, year | 59 ± 10 | 64 ± 10 | 58 ± 10 | 0.009* |
Male | 148 (73) | 21 (70) | 127 (73) | 0.735 |
Body mass index, kg/m2 | 22.9 ± 2.7 | 22.8 ± 2.9 | 23.0 ± 2.6 | 0.814 |
Systolic blood pressure, mm Hg | 129 ± 17 | 134 ± 18 | 128 ± 17 | 0.096 |
Diastolic blood pressure, mm Hg | 78 ± 11 | 79 ± 14 | 77 ± 11 | 0.551 |
Heart rate, bpm | 70 ± 10 | 70 ± 11 | 71 ± 11 | 0.729 |
Smoke | 50 (24.5) | 7 (23.3) | 43 (24.7) | 0.871 |
Hypertension | 119 (58.3) | 22 (73.3) | 97 (55.7) | 0.071 |
Diabetes | 72 (35.3) | 15 (50.0) | 57 (32.8) | 0.068 |
ACEI/AT2-antagonists | 81 (39.7) | 16 (53.3) | 65 (37.4) | 0.099 |
Beta-blockers | 121 (59.3) | 20 (66.7) | 101 (58.0) | 0.375 |
Calcium blocker | 99 (48.5) | 12 (40.0) | 87 (50.0) | 0.311 |
Aspirin | 168 (82.4) | 25 (83.3) | 143 (82.2) | 0.879 |
Revascularization therapy | ||||
PCI | 33 (16.2) | 7 (23.3) | 26 (14.9) | 0.269 |
CABG | 90 (44.1) | 15 (50.0) | 75 (43.1) | 0.482 |
Carotid plaque | 128 (62.7) | 20 (66.7) | 108 (62.1) | 0.630 |
ST depression ≥ 0.5 mm | 77 (37.7) | 13 (43.3) | 64 (36.8) | 0.494 |
T wave inversion ≥ 1 mm | 67 (32.8) | 14 (46.7) | 53 (30.5) | 0.081 |
Pathological Q wave ≥ 0.04 s | 32 (15.7) | 4 (13.3) | 28 (16.1) | 0.701 |
Location of significant stenosis | ||||
LAD | 152 (74.5) | 26 (86.7) | 126 (72.4) | 0.098 |
LCX | 114 (55.9) | 21 (70.0) | 93 (53.4) | 0.092 |
RCA | 111 (54.4) | 21 (70.0) | 90 (51.7) | 0.063 |
NYHA functional class III–IV | 61 (29.9) | 16 (53.3) | 45 (25.9) | 0.002* |